Bioanalytical Services

Introduction Stability testing in bioanalysis, as outlined in the ICH M10 guideline, provides scientific evidence that every stage of sample […]

Introduction Oligonucleotide Bioanalytical Services refer to specialized qualitative and quantitative analytical testing used to characterize pharmacokinetic (PK), pharmacodynamic (PD), and

Bioanalytical CRO for Oncology Clinical Trials: Complex Matrices, PD Biomarkers, and Regulatory Expectations Within the highly specialized field of oncology

Introduction: When evaluating a contract research organization (CRO) for your drug development program, one of the first practical questions you

Introduction: Bioanalytical method development for mRNA therapeutics is fundamentally different from conventional drug modalities — and getting it wrong at

Introduction Developing reliable bioanalytical assays for emerging therapeutic modalities requires navigating an increasingly complex biophysical environment. When establishing analytical strategies

Introduction Within the highly specialized field of drug development, implementing advanced Bioanalytical Services for Rare Disease programs is essential for

Navigating Clinical Translation of CNS Small Molecules Under FDA Fast Track The clinical translation of central nervous system (CNS)-active small

Introduction: A bioanalytical method validation failure is one of the most operationally significant and regulatorily sensitive events in drug development.